Effects of sevoflurane dose and mode of ventilation on cardiopulmonary function and blood biochemical variables in horses

American Journal of Veterinary Research

Volumn 66, Issue 4, 2005, Pages 606-614

  Steffey, Eugene P ^a   Mama, Khursheed R ^c   Galey, Frank D ^b,d   Puschner, Birgit ^b   Woliner, Michael J ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

^d Department of Ecosystem Science and Management   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; FLUORIDE; IDITOL DEHYDROGENASE; INORGANIC COMPOUND; NONSTEROID ANTIINFLAMMATORY AGENT; SEVOFLURANE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; APNEA; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORSE; INHALATION ANESTHESIA; LUNG VENTILATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MYOPATHY; NONHUMAN; RESPIRATORY FUNCTION;

ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HORSES; MALE; METHYL ETHERS; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS; MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 17544373496     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.606     Document Type: Article

References (32)

1. Mizuno Y, Ohashi N, Aida H. Anesthetic management with sevoflurane for internal fixation of long bone fracture in a horse. J Equine Sci 1996;7:47-50.
2. Matthews NS, Hartsfield SM, Carroll GL, et al. Sevoflurane anaesthesia in clinical equine cases: maintenance and recovery. J Vet Anaesth 1999;26:13-17.
3. Ohta M, Oku K, Yamanaka T, et al. Anesthetic management with sevoflurane and oxygen for orthopedic surgeries in racehorses. J Vet Med Sci 2000;62:1017-1020.
4. Carroll GL, Hooper RN, Rains CB, et al. Maintenance of anaesthesia with sevoflurane and oxygen in mechanically-ventilated horses subjected to exploratory laparotomy treated with intra- and post operative anaesthetic adjuncts. Equine Vet J 1998;30:402-407.
5. Aida H, Steffey EP, Pascoe JR, et al. Use of sevoflurane for anesthetic management of horses during thoracotomy. Am J Vet Res 2000; 61:1430-1437.
6. Driessen B, Zarucco L, Steffey EP, et al. Serum fluoride concentrations, biochemical and histopathological changes associated with prolonged sevoflurane anaesthesia in horses. J Vet Med A Physiol Pathol Clin Med 2002;49:337-347.
7. Hikasa Y, Takase K, Ogasawara S. Sevoflurane and oxygen anaesthesia following administration of atropine-xylazine-guaifenesin-thiopental in spontaneously breathing horses. J Vet Med A Physiol Pathol Clin Med 1994,41:700-708.
8. Aida H, Mizuno Y, Hobo S, et al. Cardiovascular and pulmonary effects of sevoflurane anesthesia in horses. Vet Surg 1996;25:164-170.
9. Grosenbaugh DA, Muir WW. Cardiorespiratory effects of sevoflurane, isoflurane, and halothane anesthesia in horses. Am J Vet Res 1998;59:101-106.
10. Yamanaka T, Oku K, Koyama H, et al. Time-related changes of the cardiovascular system during maintenance anesthesia with sevoflurane and isoflurane in horses. J Vet Med Sci 2001; 63:527-532.
11. Steffey EP, Howland D Jr. Comparison of circulatory and respiratory effects of isoflurane and halothane anesthesia in horses. Am J Vet Res 1980;41:821-825.
12. Steffey EP, Dunlop CI, Farver TB, et al. Cardiovascular and respiratory measurements in awake and isoflurane-anesthetized horses. Am J Vet Res 1987;48:7-12.
13. Steffey EP, Howland D Jr, Giri S, et al. Enflurane, halothane, and isoflurane potency in horses. Am J Vet Res 1977;38:1037-1039.
14. Mama KR, Steffey EP, Pascoe PJ. Evaluation of propofol as a general anesthetic for horses. Vet Surg 1995;24:188-194.
15. Mama KR, Steffey EP, Pascoe PJ. Evaluation of propofol for general anesthesia in premedicated horses. Am J Vet Res 1996;57:512-516.
16. Aida H, Mizuno Y, Hobo S, et al. Deterimination of the miniumum alveolar concentration (MAC) and physical response to sevoflurane inhalation in horses. J Vet Med Sci 1994;56:1161-1165.
17. Steffey EP, Pascoe PJ, Woliner MJ, et al. Effects of xylazine hydrochloride during isoflurane-induced anesthesia in horses. Am J Vet Res 2000;61:1225-1231.
18. Muir WW III, Sams R. Effects of ketamine infusion on halothane minimal alveolar concentration in horses. Am J Vet Res 1992;53:1802-1806.
19. White PF, Johnston RR, Pudwill CR. Interaction of ketamine and halothane in rats. Anesthesiology 1975;42:179-186.
20. Matthews NS, Hartsfield SM, Mercer D, et al. Recovery from sevoflurane anesthesia in horses: comparison to isoflurane and effect of postmedication with xylazine. Vet Surg 1998;27:480-485.
21. Eger EI II, Johnson BH. Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in rats. Anesth Analg 1987;66:977-982.
22. Whitehair KJ, Steffey EP, Willits NH, et al. Recovery of horses from inhalation anesthesia. Am J Vet Res 1993;54:1693-1702.
23. Steffey EP, Zinkl J, Howland D Jr. Minimal changes in blood cell counts and biochemical values associated with prolonged isoflurane anesthesia of horses. Am J Vet Res 1979;40:1646-1648.
24. Steffey EP, Farver T, Zinkl J, et al. Alterations in horse blood cell count and biochemical values after halothane anesthesia. Am J Vet Res 1980;41:934-939.
25. Grandy JL, Steffey EP, Hodgson DS, et al. Arterial hypotension and the development of postanesthetic myopathy in halothane-anesthetized horses. Am J Vet Res 1987;48:192-197.
26. Steffey EP, Willits N, Woliner M. Hemodynamic and respiratory responses to variable arterial partial pressure of oxygen in halothane-anesthetized horses during spontaneous and controlled ventilation. Am J Vet Res 1992;53:1850-1858.
27. Whitehair KJ, Steffey EP, Woliner MJ, et al. Effects of inhalation anesthetic agents on response of horses to three hours of hypoxemia. Am J Vet Res 1996;57:351-360.
28. Cook TL, Beppu WJ, Hitt BA, et al. Renal effects and metabolism of sevoflurane in Fischer 344 rats: an in-vivo and in-vitro comparison with methoxyflurane. Anesthesiology 1975;43:70-77.
29. Martis L, Lynch S, Napoli MD, et al. Biotransformation of sevoflurane in dogs and rats. Anesth Analg 1981;60:186-191.
30. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981;54:100-106.
31. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 1973;225:1611-1616.
32. Kharasch ED, Hankins DC, Thummel KE. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 1995;82:689-699.